Financings in Brief: IsoTis BV
This article was originally published in The Gray Sheet
Executive Summary
IsoTis BV: Private financing round led by existing shareholder Atlas Venture and including new investors GIMV and 3i raises $2 mil. The privately held developer of hybrid technology for application in hard and soft tissue replacement notes the financing "will enable us to accelerate the development of our biomimetic and tissue engineering bone and skin replacement products." Bilthoven, The Netherlands-based IsoTis recently changed its name from Matrix Medical; the new name is "analogous" to the firm's replacement tissue technologies and means "equal to tissue," IsoTis explains...